Korean Heart Failure Registry III

Acute Heart Failure Clinical Trial

— KorHF-III  

Official title:

Korean Heart Failure Registry Ⅲ of Korean Society of Heart Failure

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04329234
• Other study ID #: KorHF-III
• Status: Recruiting
• Start date: October 1, 2018
• Est. completion date: December 31, 2027

Study information

• Verified date: March 2020
• Source: Seoul National University Bundang Hospital
• Contact: Dong-Ju Choi, MD, PhD
• Phone: 82317877007
• Email: djchoi[@]snubh.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea.

The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 31, 2027
• Est. primary completion date: December 31, 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4

Inclusion Criteria:

1. Symptoms of heart failure

2. Signs of heart failure

3. Lung congestion in Chest-x-ray

4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels

Exclusion Criteria:

1. Patients younger than 18 years old

2. Patients who do no consent

Related Conditions & MeSH terms

• Acute Heart Failure
• Heart Failure

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Bundang Hospital	Seongnam

Sponsors (2)

Lead Sponsor	Collaborator
Seoul National University Bundang Hospital	Korean Society of Heart Failure

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	In-hospital mortality	In-hospital mortality	5 years
Primary	Post-discharge mortality	Post-discharge mortality	5 years
Primary	Post-discharge re-hospitalization	Post-discharge re-hospitalization	5 years